Phase I/II clinical trial - Gynécologie - Ovaires
PiSARRO
Gynécologie - Ovaires
Essai clinique fermé
Public cible
Adulte
p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin/Pegylated Liposomal Doxorubicin Combination Chemotherapy With or Without APR-246.
Description de l'essai
Ovarian cancer.
Liens utiles
![PAUL-HENRI COTTU Vignette](/sites/default/files/styles/carre_petit/public/annuaire/00930239-65685c7f9ffb5.jpg?h=78aab1d8&itok=yNo6KPGI)
PAUL-HENRI COTTU
Investigateur principal